Parathyroid adenoma

 

Epidemiology and Etiology:

    • All age groups
      • 50-60y peak
    • F:M = 3:1

 

Common sites:

    • In proximity to the thyroid
    • ectopic sites:
      • mediastinum
      • lingual

 

Gross features:

    • almost always solitary
      • other parathyroid glands should be normal size or shrunken
    • 0.5-300g (most 0.2-1.0g)
    • well-circumscribed
    • soft
    • tan to reddish-brown
    • yellow-brown rim of normal gland tissue (50-60%)

 

Histologic features:

    • delicate capsule
    • rim of compressed, non-neoplastic parathyroid tissue, outside of capsule
    • uniform, polygonal chief cells with small, centrally-placed nuclei
      • chief cell adenoma
    • follicular architecture may be seen
    • may have bizarre, pleomorphic nuclei
    • mitoses unhelpful, but usually < 1 per 10HPF
    • a few nests of larger oxyphil cells
      • uncommonly may comprise the entire adenoma (oxyphil adenoma)
    • inconspicuous adipose tissue within adenoma (in contrast to normal parathyroid)
    • background of hyperplasia suggests MEN 1
    • oxyphil adenoma:
      • composed entirely of oxyphil cells
    • massive infarction may occur (spontaneous or following FNA, may be associated with hypercalcemic crisis)
    • lipoadenoma
      • lots of fat with only scattered nests, cords, anastomosing trabeculae of chief cells
      • may be a hamartoma

 

Immunophenotype:

Marker:

Sensitivity:

Specificity:

 PTH

 

 

Chromogranin A

 

 

Argyrophil reaction

 

 

LMWK

 

 

TTF-1 (neg)

 

 

MIB-1 (usually <=5%)

 

 

 

Molecular features:

    •  sporadic:
      • PRAD1/PTH translocations (10-20%)
        1. pericentromeric inversion putting PRAD1 (encoding cyclin D1) in the transcriptional regulation of PTH
      • Cyclin D1 overexpression (40%)
      • MEN1 mutations to both copies (10-20% of sporadic)
    • Familial:
      • MEN 1 (background of hyperplasia)
    • Cytogenetics:
      • Losses of 1p/q, 6q, 11 (11q23 and 11q13/MEN1), 13q, 15q

 

Other features:

    •  

 

References:

    •  Robbins & Cotran Pathologic Basis of Disease (2005)
    • WHO Tumours of Endocrine Organs (2004)